The impact of the strength and promiscuity of the self peptide-MHC class II interaction on susceptibility to autoimmune disease is uncertain. Here we studied allelic differences in the affinity of rat MHC class II molecules for myelin basic protein (MBP) peptides spanning from position 63 to 106. Predominantly peptides from this region are immunogenic in the rat and the MHC class II region determines if the response is disease promoting or disease protective. Strikingly, RT1.B (DQ-like) molecules showed much more allelic variation of MBP peptide binding than RT1.D (DR-like) molecules. Moderate to strong binding of particular MBP peptides correlated with their previously documented encephalitogenicity. Moreover, the differences in disease susceptibility to certain MBP peptides observed in the different rat strains were clearly reflected in the allelic diversity of the peptide binding profiles. In conclusion our findings demonstrate that diseaseinducing stretches of MBP generally comprise good binding peptides.
Introduction
Susceptibility to autoimmune diseases such as insulinations in general, and give hints on the utility of such studies in designing selective immunotherapies targeting the trimolecdependent diabetes mellitus, rheumatoid arthritis and multiple sclerosis (MS) is associated with specific MHC haplotypes ular complex consisting of MHC molecule, TCR and peptide. Experimental autoimmune encephalomyelitis (EAE) repres-(1). Although not formally proven, these associations might well arise from the allelic differences in presentation of self ents a prototype autoimmune disease and is an animal model for MS. The autoagressive attack is mainly mediated by CD4 ϩ or self-mimicking foreign peptides by MHC class I or class II molecules to autoagressive T cells, in turn leading to organ-T cells (3) which can be activated in susceptible mouse or rat strains upon immunization with central nervous system specific tissue inflammation. In addition to such peripheral events, preferences in MHC peptide binding might also affect proteins such as MBP, proteolipid protein or myelin oligodendrocyte glycoprotein. A long-standing goal has been to the shaping of the T cell repertoire in the thymus leading to susceptibility to or protection from autoimmune disease (2) .
exactly define the autoantigen which is relevant for inducing and/or perpetuating autoimmune disease, and in addition to Despite these hypotheses, there are little experimental data on how allelic variations in peptide binding relate to immunodefine which epitopes within this particular autoantigen are encephalitogenic. In EAE this is dependent on the MHC genicity and disease-inducing potential of peptides derived from autoantigens in well-defined animal models. This matter haplotype (4-6), and the major genetic influence most likely is exerted by MHC class I and class II molecules since is not trivial since better definition of allelic variations in MHC class II peptide binding in relation to disease-inducing they are the peptide-presenting elements and display allelic diversity. Among autoantigens in autoimmune neuroinflammapotential would enable a better understanding of MHC associ-tory disease most interest so far has been devoted to MBP. 
Synthetic peptides
For the MBP numbering system used, see Eylar et al. (15) The N-terminally biotinylated tracer peptides MBP 87-99, MBP 83-97, CLIP 97-120 and P2 58-81 and their nonbiotinylated equivalents (Table 1) were synthesized by the F-moc/HBTU strategy (Dr Å. Engströ m, Department of and finally bound MHC molecules were eluted with 0.05 M Medical and Physiological Chemistry, University of Uppsala, diethylamine, pH 11/0.15 M NaCl/0.1% octyl-β-D-glucopyrUppsala, Sweden). Peptides were purified by reversedanoside. After neutralization with 2 M Tris-HCl, pH 6.3, the phase chromatography and subsequently analyzed by purity of the eluted proteins was assessed by SDS-PAGE plasma desorption mass spectroscopy. The stepped 13mer
and subsequent silver staining. The presence of stable MBP peptides were similarly synthesized and generously MHC class II complexes for each of the haplotypes was provided by Ferring (Malmö , Sweden).
confirmed by running the proteins in SDS-PAGE without denaturation through boiling. The protein content was
Purification of RT1.B and RT1.D molecules
measured with the BCA protein assay (Pierce, Rockford, IL) using BSA as a standard. The different RT1.B and RT1.D molecules were purified from MHC congenic LEW rat (LEW, LEW.1A, LEW.1N and Peptide binding assay LEW.1W) thymic and splenic tissues by affinity chromatography using OX-6 (specific for RT1.B molecules) and OXRelative affinities of MBP peptides for purified RT1.B and RT1.D molecules were assessed by an inhibition ELISA 17 (specific for RT1.D molecules) antibodies as described previously (16) . Briefly, tissues were lysed in PBS containing based on a dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA; Wallac, Turku, Finland) as described 1% NP-40 (Boehringer, Mannheim, Germany) in the presence of a cocktail of protease inhibitors. The lysates were cleared previously (17). Initially, biotinylated tracer peptides were used in a direct binding assay to establish optimal binding of nuclei and debris by centrifugation at 50,000 g for 60 min and subsequent passage over a 45 µm filter. The conditions for each of the purified RT1.B and RT1.D molecules. cleared lysates were cycled over OX-6-and OX-17-coupled CNBr-activated Sepharose-4B (Pharmacia, Uppsala, In the inhibition ELISA assay, RT1.B and RT1.D (50-100 nM) molecules were incubated with fixed amounts of their Sweden) columns. The columns were washed with 20 column volumes of PBS/0.1% SDS/0.5% NP-40, three column respective tracer peptides (10-50 nM) ( Table 2) Inhibition studies were routinely performed at pH 5, since pH titration experiments had shown that this was the optimal pH for binding of the tracer to most of the purified MHC molecules. The binding buffer consisted of a carbonate buffer titrated to pH 5 containing 2 mM EDTA, 0.01% azide, 0.1 mM PMSF and 0.1% Nonidet P-40 (Boehringer). After an incubation of 48 h at room temperature, the peptide-MHC complexes were transferred to antibody coated (OX-6 or OX-17) ELISA plates (FluoroNunc; Nunc, Roskilde, Denmark) to remove the excess of non-bound peptides. Europium-labeled streptavidin (Wallac) was added to the plates and incubated for 1 h at room temperature. Finally, the plates were treated with an enhancement solution (Wallac), which releases chelated europium from streptavidin and forms a highly fluorescent miscellar solution that can be measured by using a DELFIA fluorometer (Wallac). The concentration yielding 50% inhibition of binding of the tracer peptide (IC 50 ) was measured by plotting the percentage of inhibition versus the concentration of MBP Table 2 . The relative affinity of the stepped MBP peptides for each of the purified RT1.D alleles was measured and expressed T cells in either rats or humans and are known to be RT1.D or HLA-DR restricted (8, 11) . Both peptides bound with the as the IC 50 value (Fig. 1) (19, 20) . We decided to use molecules will not induce disease since it cannot be presented to T cells. If binding of MBP peptides to the proper MHC molecules does occur, lack of disease induction can be caused by holes in the T cell repertoire due to inactivation of high-avidity T cells by endogenously expressed MBP (21) . Alternatively, activation of peptidespecific regulatory T cells secreting disease down-regulatory cytokines or peripheral tolerization of T cells might lead to disease protection. Only in the case of recruitment and activation of autoreactive T cells producing inflammatory cytokines will EAE ensue. To study the role of the MHC molecules in these processes in more detail, we analyzed the binding data obtained for the four different rat MHC class II haplotypes in regard to previously published results obtained in EAE actively induced with MBP encompassing the MBP 63-106 region.
Results

Definition of tracer peptides for the purified MHC class II
Both DA and LEW rats are susceptible to EAE upon immunization with the RT1.B-restricted MBP 68-86 peptide (22). The minimal encephalitogenic peptide for LEW rats, the RT.B l -restricted MBP 73-86 peptide (23,24), does not induce disease in DA rats. The encephalitogenic epitopes for DA rats in the MBP 68-86 region have been mapped to MBP 63-76, MBP 66-81 and to the C-terminal residues MBP 79-86 (25,26). Clearly, the non-overlapping character of the encephalitogenic epitopes for LEW and DA rats parallels the RT1.B a and RT1.B l binding patterns, which do not overlap either ( Table 3) .
The existence of both regulatory and disease-inducing MBP peptides has been demonstrated previously (13, 14) . The MBP 62-89 peptide induces a disease-promoting T h 1 response in LEW rats with the RT1 a and RT1 l haplotypes, while a protective T h 2 response is elicited in connection with the RT1 u haplotype. Both the RT1.B a and the RT1.B l Table 2. peptides in this region with very low affinity (IC 50 Ͼ 10 µM). Interestingly, it has been shown that the interaction between TCR, peptide and MHC molecule can determine T h 1/T h 2 dominance in certain defined experimental sysprofile, thus showing more allelic diversity (Fig. 2) . The RT1.B a molecule displayed the most promiscuous binding tems (28, 29) . Upon immunization with the subdominant MBP 87-99 of MBP peptides with several peptides binding with IC 50 values as low as 50 nM. For the RT1.B l molecule, binding peptide, LEW.1W-derived splenocytes do not respond in a measurable way (14) . This non-responsiveness is in comwas limited to the immunodominant RT1.B l -restricted MBP 62-89 region. Intermediate binding affinities were revealed plete correlation with the lack of binding affinity for RT1.B u and RT1.D u molecules (IC 50 Ͼ 100 µM) ( Table 3 ). In for this allele with IC 50 values in the micromolar range. The profile of peptides binding to the RT1.B n molecule showed contrast, LEW rats with the MHC class II alleles RT1 l , RT1 a and RT1 n develop disease after immunization with MBP more similarity to that observed in the RT1.D n molecules. Peptide binding was concentrated to the MBP 87-99 region 87-99. The restriction elements for MBP 87-99 in the RT1 l and RT1 a haplotypes are the RT1.D l and RT1.B a molecules and some of the peptides bound in this region with IC 50 values Ͻ 1 µM. For the RT1.B u molecule just a few weakly respectively, and relatively good binding of this peptide is observed in both cases (IC 50 10-100 nM). binding peptides (IC 50 Ͼ 10 µM) could be detected in the MBP 62-89 region.
The pathogenic importance of the affinity of autoantigenic peptides to the class II molecule has been a continuous point of debate. Low-affinity binding is compatible with the Discussion idea that autoreactive T cells escape tolerance (30) , while high-affinity binding of autoantigens would require breaking The issue we addressed with this study is how MHCpeptide binding relates to autoimmune T cell responses of tolerance or regulatory recognition. Our study shows that the elicitation of an immune response, whether of the T h 1 and disease outcome in an MBP-induced EAE model. By common sense, an MBP peptide not binding to MHC or the T h 2 type, corresponds to the presence of T cell (8, 31) .
of the larger number of encephalitogenic MBP peptides which can bind and be presented to T cells (37, 38) . While By analyzing the experimental data in more depth we observed isotype-dependent differences in the RT1.B and human MS is associated to a particular HLA class II haplotype, i.e. DRB1*1501, DQA1*0102 and DQB1*0602, RT1.D molecule MBP peptide binding patterns. Whereas the RT1.B molecules displayed striking allelic differences association studies have suggested several class II molecules from both DR and DQ loci (39-41). Possibly, several in the spectrum of binding peptides, the RT1.D molecules bound similar MBP stretches, mainly in the MBP 87-99 of them play a role as binders of various myelin proteinderived peptides as has been shown to occur in the rat. region. The importance of this sequence has been amply documented in humans, where it was shown that MBP
In conclusion, the present study demonstrates that differences in disease susceptibility to certain MBP peptides epitopes in this region are recognized in the context of several MS associated HLA-DR types (32). The overlapping in different rat strains can partially be explained by allelic diversity of the MHC class II peptide binding patterns. of the RT1.D binding patterns is in line with recent data obtained by Southwood et al. (33) showing that several Moreover, although the role of the MHC class II molecule in the MHC class II associations to EAE is still not formally common HLA-DR types share largely overlapping peptide binding repertoires characterized by the presence of a proven, our data strongly argue for a crucial function of the MHC class II molecule itself in the observed effects. common P1-P6 supermotif. This might have a structural basis since the RT1.D locus is less polymorphic than the RT1.B locus (34, 35 
